- Home
- UFI vs GNLX Comparison
UFI vs GNLX Comparison
Compare UFI & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UFI
- GNLX
- Stock Information
- Founded
- UFI 1969
- GNLX 2001
- Country
- UFI United States
- GNLX United States
- Employees
- UFI N/A
- GNLX N/A
- Industry
- UFI Textiles
- GNLX Biotechnology: Pharmaceutical Preparations
- Sector
- UFI Consumer Discretionary
- GNLX Health Care
- Exchange
- UFI Nasdaq
- GNLX Nasdaq
- Market Cap
- UFI 91.3M
- GNLX 96.6M
- IPO Year
- UFI N/A
- GNLX 2023
- Fundamental
- Price
- UFI $4.87
- GNLX $2.83
- Analyst Decision
- UFI
- GNLX Strong Buy
- Analyst Count
- UFI 0
- GNLX 4
- Target Price
- UFI N/A
- GNLX $17.75
- AVG Volume (30 Days)
- UFI 38.8K
- GNLX 157.9K
- Earning Date
- UFI 04-30-2025
- GNLX 08-13-2025
- Dividend Yield
- UFI N/A
- GNLX N/A
- EPS Growth
- UFI N/A
- GNLX N/A
- EPS
- UFI N/A
- GNLX N/A
- Revenue
- UFI $590,261,000.00
- GNLX N/A
- Revenue This Year
- UFI $1.08
- GNLX N/A
- Revenue Next Year
- UFI $9.96
- GNLX N/A
- P/E Ratio
- UFI N/A
- GNLX N/A
- Revenue Growth
- UFI 2.51
- GNLX N/A
- 52 Week Low
- UFI $4.25
- GNLX $1.60
- 52 Week High
- UFI $7.91
- GNLX $5.89
- Technical
- Relative Strength Index (RSI)
- UFI 47.76
- GNLX 57.73
- Support Level
- UFI $4.83
- GNLX $2.85
- Resistance Level
- UFI $5.12
- GNLX $3.29
- Average True Range (ATR)
- UFI 0.22
- GNLX 0.22
- MACD
- UFI -0.01
- GNLX 0.06
- Stochastic Oscillator
- UFI 27.59
- GNLX 64.74
About UFI Unifi Inc. New
Unifi Inc is a multi-national company. It manufactures and sells synthetic and recycled products made from polyester and nylon predominantly to other yarn manufacturers and knitters and weavers that produce fabric for apparel, hosiery, home furnishings, automotive, industrial, and other end-use markets. Polyester yarns include partially oriented yarn (POY), textured, solution and package dyed, twisted, beamed, and draw wound yarns, and each is available in virgin or recycled varieties. UNIFI offers specialized yarns, premium value-added (PVA) yarns, and commodity yarns. The company's reportable segments are; the Americas, Brazil, and Asia. Its maximum revenue is derived from the Americas.
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.